[Federal Register Volume 75, Number 206 (Tuesday, October 26, 2010)]
[Notices]
[Page 65660]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-27035]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated October 21, 2009 and published in the Federal 
Register on October 28, 2009, (74 FR 55586), Archimica, Inc., 2460 W. 
Bennett Street, Springfield, Missouri 65807-1229, made application by 
letter to the Drug Enforcement Administration (DEA) to be registered as 
a bulk manufacturer of Tapentadol (9780, a basic class of controlled 
substance listed in schedule II.
    The company plans to manufacture the listed controlled substance in 
bulk for distribution to its customers.
    One comment objecting to the granting of registration as a bulk 
manufacturer of the basic class of controlled substance listed to this 
applicant was received. However, after a thorough review of this 
matter, DEA has concluded that the issues raised in the comment and 
objection do not warrant the denial of this application.
    DEA has considered the factors in 21 U.S.C. 823(a) and determined 
that the registration of Archimica, Inc. to manufacture the listed 
basic class of controlled substance is consistent with the public 
interest at this time. DEA has investigated Archimica, Inc. to ensure 
that the company's registration is consistent with the public interest. 
The investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance 
with 21 CFR 1301.33, the above named company is granted registration as 
a bulk manufacturer of the basic class of controlled substance listed.

    Dated: October 19, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2010-27035 Filed 10-26-10; 8:45 am]
BILLING CODE 4410-09-P